New Caledonia vs Tuvalu: The number of people with susceptibility test result for rifampicin
New Caledonia
100
in 2021
Tuvalu
100
in 2021
New Caledonia rank
2nd
Tuvalu rank
2nd
The number of people with susceptibility test result for rifampicin over time
- New Caledonia
- Tuvalu
How they compare
New Caledonia currently reports 100 against 100 in Tuvalu, a difference of 0.
The two have swapped places 4 times across 5 shared years of data; in 2017 it was Tuvalu ahead.
New Caledonia ranks 2nd and Tuvalu ranks 2nd of 146 countries.
Across the 2 decades both report, New Caledonia averaged higher in 1 and Tuvalu in 1.
Head to head by decade
| Decade | New Caledonia | Tuvalu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 100 | 114.29 | 14.29 | Tuvalu |
| 2020s | 100 | 96.88 | 3.12 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, New Caledonia or Tuvalu?
- New Caledonia, at 100 against 100 in Tuvalu as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between New Caledonia and Tuvalu?
- 0, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Tuvalu?
- 5 years are reported by both, from 2017 to 2021.
- How do New Caledonia and Tuvalu rank globally for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 2nd and Tuvalu ranks 2nd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.